CD40LG and anogenital human papillomavirus infection: Among the clinically symptomatic Indigenous individuals, anti-HSV-2 IgM was detected in 14.2%, 12.3%, 15.4%, and 14.5% of those exhibiting urinary problems, genital wounds, genital warts, and urethral discharge, respectively (Table 3).